Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06597526
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-10
Brief Title:
The Role of 18F-FDGamp68Ga-FAPI PETCT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Role of 18F-FDG ampampampampampamp 68Ga-FAPI PETCT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastatic
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the value of 18F-FDGamp68Ga-FAPI PETCT in evaluating the outcome of conversion therapy and the prognosis of people with peritoneal metastases from gastric cancer
Detailed Description:
If the target population of the study agrees to participate in the study we will number the participants resume their pathology files and collect their gender age phone number height and weight information record the participants39 consultation process and the results of the tests and examinations therein During the course of the study we will perform 18F-FDG amp 68Ga-FAPI PETCT according to the participant39s stage of disease specifically one 18F-FDG PETCT prior to conversion therapy and one 68Ga-FAPI PETCT as a baseline assessment One 18F-FDG PETCT and one 68Ga-FAPI PETCT were performed before the clinician assessed that the conversion therapy was ready to be completed and the conversion surgery was about to be performed and if the participant experienced a postoperative recurrence of the disease during the study period another 18F-FDG PETCT and a 68Ga-FAPI PETCT would be performed meaning that a total of 4 PETCTs were performed In other words a total of 4 PETCT visualizations were required for all participants 2 additional PETCT visualizations including 18F-FDG PETCT and 68Ga-FAPI PETCT were performed if the disease recurred after the conversion surgery and none were required for participants without recurrence
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None